In this episode, Jeremy Schmerer and Ryan LaRanger discuss the idea of a “Lab on a Chip,” which allows for better screening and discovery work. One example involves the ability to simulate potential drug development failures early in the process, before they become extremely expensive to the drug maker. Other subjects addressed include:
- Cardio Toxicity
- Biomarkers
- Chemotherapeutics
- Animal Models
- Testing Cost and Scalability
